The Mounting Burden of Neurological Disease

A new analysis provides a comprehensive update on this significant, and growing, cause of disability and death.

Related Videos
Related Content

Understanding the Risk of Multiple Sclerosis in Patients With HIV

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

BrainStorm Announces FDA AdComm Meeting for NurOwn Stromal Cell Therapy

March 27th 2023

Neuro News Roundup: Purple Day

March 26th 2023

Understanding the Risk of Multiple Sclerosis in Patients With HIV

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

BrainStorm Announces FDA AdComm Meeting for NurOwn Stromal Cell Therapy

March 27th 2023

Neuro News Roundup: Purple Day

March 26th 2023

Understanding the Risk of Multiple Sclerosis in Patients With HIV

March 28th 2023

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Special Episode: Trofinetide Approved for Rett Syndrome

March 13th 2023

BrainStorm Announces FDA AdComm Meeting for NurOwn Stromal Cell Therapy

March 27th 2023

Neuro News Roundup: Purple Day

March 26th 2023
© 2023 MJH Life Sciences

All rights reserved.